Eligo Bioscience is a pioneering brand in the field of genetic engineering. Established in 2014 by scientists from Rockefeller University and MIT, Eligo Bioscience aims to translate academic inventions into a powerful therapeutic platform. Led by a management team and board members with impressive credentials and accolades, including being named French Innovator of the Year and recognized by organizations like Forbes and the World Economic Forum, Eligo Bioscience is at the forefront of innovation.

With a strong international and interdisciplinary team, Eligo Bioscience brings together talented scientists in synthetic biology, microbiology, and immunology, along with experienced developers and executives, to develop impactful products. Their platform utilizes synthetic biology, animal models, discovery and automation, and more to create revolutionary solutions. Eligo Bioscience takes pride in fostering a diverse and inclusive work environment, with a 1:1 gender ratio and a LGBTQ-friendly business culture.

They are actively seeking new talent to join their team. Eligo Bioscience: revolutionizing genetic engineering for a better future